Retrospective Clinical Investigation into the Association Between Abnormal Blood Clotting, Oral Anticoagulant Therapy, and Medium-Term Mortality in a Cohort of COVID-19 PatientsBIOMEDICINESIF3.92025-02-201OAAI
Advances in synthesis of novel annulated azecines and their unique pharmacological propertiesEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92024-12-010PRE
Chiral pyrrolidines as multipotent agents in Alzheimer and neurodegenerative diseasesBIOORGANIC & MEDICINAL CHEMISTRYIF32024-08-013OAAI
Pleiotropic Effects of Direct Oral Anticoagulants in Chronic Heart Failure and Atrial Fibrillation: Machine Learning Analysis直接口服抗凝剂在慢性心力衰竭和心房颤动中的多效作用: 机器学习分析MOLECULESIF4.62024-06-042OAAI
Novel 6-alkyl-bridged 4-arylalkylpiperazin-1-yl derivatives of azepino [4,3-b]indol-1(2H)-one as potent BChE-selective inhibitors showing protective effects against neurodegenerative insultsEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92024-04-016OAAI
Small Molecules for the Treatment of Long-COVID-Related Vascular Damage and Abnormal Blood Clotting: A Patent-Based AppraisalVIRUSES-BASELIF3.52024-03-144OAAI
Synthesis, computational and experimental pharmacological studies for (thio)ether-triazine 5-HT6R ligands with noticeable action on AChE/BChE and chalcogen-dependent intrinsic activity in search for new class of drugs against Alzheimer's diseaseEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92023-11-018OAAI
Assessing the Role of a Malonamide Linker in the Design of Potent Dual Inhibitors of Factor Xa and CholinesterasesMOLECULESIF4.62022-07-028OAAI